Heart Disease News and Research RSS Feed - Heart Disease News and Research

Findings could help design tailor-made drugs to treat blood pressure

Findings could help design tailor-made drugs to treat blood pressure

One in three Americans has high blood pressure, a long-term constriction of arteries that can lead to coronary heart disease, heart failure and stroke. [More]
Study shows that Hodgkin lymphoma patients can remain disease-free with just chemotherapy alone

Study shows that Hodgkin lymphoma patients can remain disease-free with just chemotherapy alone

In a paper published in the New England Journal of Medicine, the scientists show that a positron-emission tomography (PET) scan immediately after treatment with chemotherapy can identify patients who have a very good outcome without additional radiotherapy. [More]
Study examines impact of smoking on cardiovascular risk in older people

Study examines impact of smoking on cardiovascular risk in older people

In the most comprehensive study ever on the impact of smoking on cardiovascular disease in older people, epidemiologist Dr. Ute Mons from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) analyzed 25 individual studies, compiling data from over half a million individuals age 60 and older. [More]
May issues of AGA's journals highlight important research updates on liver disease

May issues of AGA's journals highlight important research updates on liver disease

The May issues of AGA's journals -- Clinical Gastroenterology and Hepatology and Gastroenterology -- highlight important research updates on the most deadly forms of liver disease. [More]
U of T studies find harmful vehicle emissions spreading farther than thought across Canadian cities

U of T studies find harmful vehicle emissions spreading farther than thought across Canadian cities

A trio of recently published studies from a team of University of Toronto engineers has found that air pollution could be spreading up to three times farther than thought--contributing to varying levels of air quality across cities. [More]
EuroPRevent congress to focus on cardiovascular disease

EuroPRevent congress to focus on cardiovascular disease

While death rates from heart disease in Europe have more than halved in many countries and in most population groups since the early 1980s, heart disease remains by far the leading cause of death. [More]
University of Birmingham researchers identify new way to tackle chronic diseases

University of Birmingham researchers identify new way to tackle chronic diseases

Researchers from the University of Birmingham have identified an important new way in which our immune systems are regulated, and hope that understanding it will help tackle the debilitating effects of type 1 diabetes, rheumatoid arthritis and other serious diseases. [More]
New CUMC study finds DNA anomalies in kids with chronic kidney disease

New CUMC study finds DNA anomalies in kids with chronic kidney disease

A significant proportion of children with chronic kidney disease (CKD) have unsuspected chromosomal imbalances, including DNA anomalies that have been linked to neurocognitive disorders, according to a new Columbia University Medical Center study. [More]
Two Louisville heart physicians to host symposium on cardiovascular disease in women

Two Louisville heart physicians to host symposium on cardiovascular disease in women

Two of Louisville's leading heart physicians will host a one-day symposium designed to provide the community, physicians, nurses and health professionals up-to-date information on the prevention, diagnosis and treatment of cardiovascular disease in women. [More]
CU Cancer Center researcher examines link between cancer, diabetes and cardiovascular disease

CU Cancer Center researcher examines link between cancer, diabetes and cardiovascular disease

In a major symposium at the American Association for Cancer Research (AACR) Annual Meeting 2015, University of Colorado Cancer Center investigator Tim Byers, MD, MPH, examines research demonstrating the link between cancer, diabetes and cardiovascular disease. [More]
MSU researchers receive $7 million NIH grant to study link between belly fat and high blood pressure

MSU researchers receive $7 million NIH grant to study link between belly fat and high blood pressure

Michigan State University researchers, who were the first to suggest that high blood pressure could be caused by belly fat hormones "talking" with blood vessels in the abdomen, have received a nearly $7 million National Institutes of Health grant to further their work. [More]
May issue of Red Journal focuses on role of radiation therapy in current lymphoma treatment

May issue of Red Journal focuses on role of radiation therapy in current lymphoma treatment

The "Radiation and the Modern Management of Lymphoma" issue (May 1, 2015) of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology, is focused on the integral role of radiation therapy in current lymphoma treatment. [More]
Autophagy: A new approach to fighting tuberculosis

Autophagy: A new approach to fighting tuberculosis

A new approach to combatting tuberculosis would take advantage of a complex, natural process called autophagy that the human body uses to recycle nutrients, remove damaged cell components, eliminate invading bacteria, and respond to inflammation. [More]
NIH-supported clinical trial to test statin use in patients with HIV-related cardiovascular disease

NIH-supported clinical trial to test statin use in patients with HIV-related cardiovascular disease

Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health's National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases. [More]
New Forsyth Institute study sheds light on connection between the mouth and heart

New Forsyth Institute study sheds light on connection between the mouth and heart

A new study from the Forsyth Institute is helping to shed more light on the important connection between the mouth and heart. According to research recently published online by the American Heart Association, scientists at Forsyth and Boston University have demonstrated that using an oral topical remedy to reduce inflammation associated with periodontitis, more commonly known as gum disease, also results in the prevention of vascular inflammation and can lower the risk of heart attack. [More]
Capillary pCO2 helps determine IPAH diagnosis

Capillary pCO2 helps determine IPAH diagnosis

Capillary pCO2 can be used to distinguish idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction, research indicates. [More]
Toronto General Hospital unveils novel technology-based platform to improve patient care

Toronto General Hospital unveils novel technology-based platform to improve patient care

The Toronto General Hospital today becomes the first healthcare institution in the world to unveil a novel technology-based platform aimed at shortening the time required to translate medical research into clinical practice. This will enable faster diagnoses and more rapid treatment for patients with heart disease and other conditions that are detected using advanced medical imaging devices. [More]
Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai Inc. and Arena Pharmaceuticals, Inc. today announced the completion of two Phase 1 registrational clinical trials that Eisai and Arena believe demonstrate bioequivalence of an investigational once-daily extended release formulation of lorcaserin, as compared to the twice-daily immediate release formulation approved by the US Food and Drug Administration and marketed as BELVIQ. [More]
Administration of selenide protects heart tissue post cardiac arrest, shows study

Administration of selenide protects heart tissue post cardiac arrest, shows study

Damage to heart muscle from insufficient blood supply during cardiac arrest and reperfusion injury after blood flow is restored can be reduced by nearly 90 percent if selenide, a form of the essential nutrient selenium, is administered intravenously in the wake of the attack, according to a new preclinical study by researchers at Fred Hutchinson Cancer Research Center. [More]
Scientists identify chemical compounds that block cancer-causing oncoprotein

Scientists identify chemical compounds that block cancer-causing oncoprotein

A team of scientists at the University of Kansas has pinpointed six chemical compounds that thwart HuR, an "oncoprotein" that binds to RNA and promotes tumor growth. [More]
Advertisement
Advertisement